92350 ⎘
Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having one nitro groups bound to the ring
Preparation method for water-soluble magnolol derivatives and honokiol derivatives and intermediates thereof, and related monohydroxy protection intermediates
#2Polyamide Acid, Polyimide, Optical Film, Display Device and Production Methods Thereof
#3Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane
#4Organophosphorus degrading enzyme based multifunctional catalyst and preparation method and use thereof
#5Organic positive electrode active material for aqueous redox flow battery
#6ARYL ETHERS AND USES THEREOF
#7ORGANIC POSITIVE ELECTRODE ACTIVE MATERIAL FOR AQUEOUS REDOX FLOW BATTERY
#8Aryl ethers and uses thereof
#9Aryl ethers and uses thereof
#10COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#11Aryl ethers and uses thereof
#12Therapeutic catechols
#13Compounds for the treatment of neurodegenerative diseases
#14Compounds for the treatment of neurodegenerative diseases
#15Self-reactive arms and prodrugs comprising same
#16Method for the hydroxylation of halogenated aryl compounds
#17Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#18METHOD FOR PREPARING 2-(n-BUTYL)-5-NITROBENZOFURAN
#19NITRATION OF ACTIVATED AROMATICS IN MICROREACTORS
#20Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#21Process for preparation of a nitrophenol
#22Process for the preparation of phenolic hydroxy-substituted compounds
#23Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
#24Method for extracting nitrocresols from waste water produced in the manufacture of mononitrotoluene and use of said extract
#25Method of synthesizing camptothecin-relating compounds
#26Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#27Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#28Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
#29Process for preparation of a nitrophenol
#30Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
#31Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods